I-Mab Announces Poster Presentations of 4-1BB Bispecific Antibody Portfolio at SITC 2023
- Written by PR Newswire
![]() |
ROCKVILLE, MD, U.S. and SHANGHAI, China, Nov. 1, 2023 /PRNewswire/ -- I-Mab (Nasdaq: IMAB) (the "Company"), a global biotechnology company focused on bringing highly differentiated medicines to patients around the world through the discovery, development, and commercialization of novel immunotherapies and biologics, today announced that two poster...
Read more: I-Mab Announces Poster Presentations of 4-1BB Bispecific Antibody Portfolio at SITC 2023